Multicenter, Randomized, Parallel Group, Phase II Study To Establish The Efficacy And Safety Of Cbp501, Cisplatin, And Nivolumab For >= Third-Line Treatment Of Patients With Exocrine Pancreatic Cancer And Wbc <10,000/Mm3
CBP-501;Cisplatin;Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Multicenter, Randomized, Parallel Group, Phase II Study To Establish The Efficacy And Safety Of Cbp501, Cisplatin, And Nivolumab For >= Third-Line Treatment Of Patients With Exocrine Pancreatic Cancer And Wbc <10,000/Mm3 ### Output: CBP-501;Cisplatin;Nivolumab